Organ Chips and Visualization of Biological Systems

Overview

Journal Adv Exp Med Biol

Specialties Biology
General Medicine

Date 2023 Jul 17

PMID 37460731

Authors

Tian Tian

Jun Liu

He Zhu

Affiliations

Soon will be listed here.

Abstract

Organ-on-a-chip (OOC) is an emerging frontier cross-cutting science and technology developed in the past 10 years. It was first proposed by the Wyss Institute for Biologically Inspired Engineering of Harvard Medical School. It consists of a transparent flexible polymer the size of a computer memory stick, with hollow microfluidic channels lined with living human cells. Researchers used bionics methods to simulate the microenvironment of human cells on microfluidic chips, so as to realize the basic physiological functions of corresponding tissues and organs in vitro. Transparent chip materials can perform real-time visualization and high-resolution analysis of various human life processes in a way that is impossible in animal models, so as to better reproduce the microenvironment of human tissue and simulate biological systems in vitro to observe drug metabolism and other life processes. It provides innovative research systems and system solutions for in vitro bionics of biological systems. It also has gradually become a new tool for disease mechanism research and new drug development. In this chapter, we will take the current research mature single-organ-on-a-chip and multi-organ human-on-a-chip as examples; give an overview of the research background and underlying technologies in this field, especially the application of in vitro bionic models in visualized medicine; and look forward to the foreseeable future development prospects after the integration of organ-on-chip and organoid technology.

Citing Articles

Effective and new technologies in kidney tissue engineering.

Rayat Pisheh H, Haghdel M, Jahangir M, Hoseinian M, Rostami Yasuj S, Roodbari A Front Bioeng Biotechnol. 2024; 12:1476510.

PMID: 39479295 PMC: 11521926. DOI: 10.3389/fbioe.2024.1476510.

References

Seok J, Warren H, Cuenca A, Mindrinos M, Baker H, Xu W . Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A. 2013; 110(9):3507-12. PMC: 3587220. DOI: 10.1073/pnas.1222878110. View

Henderson V, Kimmelman J, Fergusson D, Grimshaw J, Hackam D . Threats to validity in the design and conduct of preclinical efficacy studies: a systematic review of guidelines for in vivo animal experiments. PLoS Med. 2013; 10(7):e1001489. PMC: 3720257. DOI: 10.1371/journal.pmed.1001489. View

Huh D, Matthews B, Mammoto A, Montoya-Zavala M, Hsin H, Ingber D . Reconstituting organ-level lung functions on a chip. Science. 2010; 328(5986):1662-8. PMC: 8335790. DOI: 10.1126/science.1188302. View

Low L, Mummery C, Berridge B, Austin C, Tagle D . Organs-on-chips: into the next decade. Nat Rev Drug Discov. 2020; 20(5):345-361. DOI: 10.1038/s41573-020-0079-3. View

Azizgolshani H, Coppeta J, Vedula E, Marr E, Cain B, Luu R . High-throughput organ-on-chip platform with integrated programmable fluid flow and real-time sensing for complex tissue models in drug development workflows. Lab Chip. 2021; 21(8):1454-1474. DOI: 10.1039/d1lc00067e. View

Vulto P, Joore J . Adoption of organ-on-chip platforms by the pharmaceutical industry. Nat Rev Drug Discov. 2021; 20(12):961-962. DOI: 10.1038/s41573-021-00323-0. View

Virumbrales-Munoz M, Ayuso J, Gong M, Humayun M, Livingston M, Lugo-Cintron K . Microfluidic lumen-based systems for advancing tubular organ modeling. Chem Soc Rev. 2020; 49(17):6402-6442. PMC: 7521761. DOI: 10.1039/d0cs00705f. View

Herland A, Maoz B, Das D, Somayaji M, Prantil-Baun R, Novak R . Quantitative prediction of human pharmacokinetic responses to drugs via fluidically coupled vascularized organ chips. Nat Biomed Eng. 2020; 4(4):421-436. PMC: 8011576. DOI: 10.1038/s41551-019-0498-9. View

10.

Williams L, Leggett R . Reference values for resting blood flow to organs of man. Clin Phys Physiol Meas. 1989; 10(3):187-217. DOI: 10.1088/0143-0815/10/3/001. View

11.

Thorsen T, Maerkl S, Quake S . Microfluidic large-scale integration. Science. 2002; 298(5593):580-4. DOI: 10.1126/science.1076996. View

12.

Thorsen T . Microfluidic tools for high-throughput screening. Biotechniques. 2004; 36(2):197-9. DOI: 10.2144/04362TE01. View

13.

Chabinyc M, Chiu D, McDonald J, Stroock A, Christian J, Karger A . An integrated fluorescence detection system in poly(dimethylsiloxane) for microfluidic applications. Anal Chem. 2001; 73(18):4491-8. DOI: 10.1021/ac010423z. View

14.

Whitesides G . The origins and the future of microfluidics. Nature. 2006; 442(7101):368-73. DOI: 10.1038/nature05058. View

15.

Wilkening S, Stahl F, Bader A . Comparison of primary human hepatocytes and hepatoma cell line Hepg2 with regard to their biotransformation properties. Drug Metab Dispos. 2003; 31(8):1035-42. DOI: 10.1124/dmd.31.8.1035. View

16.

Hamilton G . Multicellular spheroids as an in vitro tumor model. Cancer Lett. 1998; 131(1):29-34. DOI: 10.1016/s0304-3835(98)00198-0. View

17.

Ong S, Zhao Z, Arooz T, Zhao D, Zhang S, Du T . Engineering a scaffold-free 3D tumor model for in vitro drug penetration studies. Biomaterials. 2009; 31(6):1180-90. DOI: 10.1016/j.biomaterials.2009.10.049. View

18.

Dubessy C, Merlin J, Marchal C, Guillemin F . Spheroids in radiobiology and photodynamic therapy. Crit Rev Oncol Hematol. 2000; 36(2-3):179-92. DOI: 10.1016/s1040-8428(00)00085-8. View

19.

Kunz-Schughart L . Multicellular tumor spheroids: intermediates between monolayer culture and in vivo tumor. Cell Biol Int. 1999; 23(3):157-61. DOI: 10.1006/cbir.1999.0384. View

20.

Yuhas J, Li A, Martinez A, LADMAN A . A simplified method for production and growth of multicellular tumor spheroids. Cancer Res. 1977; 37(10):3639-43. View

21.

Tung Y, Hsiao A, Allen S, Torisawa Y, Ho M, Takayama S . High-throughput 3D spheroid culture and drug testing using a 384 hanging drop array. Analyst. 2010; 136(3):473-8. PMC: 7454010. DOI: 10.1039/c0an00609b. View